| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 01/01/2018 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/01/2010 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 01/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 01/01/2017 |
| Chairman | 46 | 01/01/2020 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 01/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -98.73% | - | - | 92.63K | |
| +0.01% | -2.47% | +57.79% | +108.23% | 1,034B | |
| +1.48% | +1.93% | +54.56% | +71.49% | 663B | |
| +0.67% | -0.45% | +23.50% | +76.60% | 462B | |
| +2.08% | -1.76% | +32.69% | +38.79% | 344B | |
| -0.30% | +5.09% | +27.07% | +47.12% | 307B | |
| +1.54% | +0.63% | -0.16% | +14.03% | 251B | |
| +1.08% | +0.57% | +54.34% | +72.51% | 239B | |
| +1.88% | +4.27% | -15.58% | -53.03% | 207B | |
| -0.21% | +1.03% | +32.74% | +95.19% | 186B | |
| Average | +0.77% | -0.70% | +29.66% | +52.33% | 410.37B | |
| Weighted average by Cap. | +0.77% | -0.84% | +38.50% | +67.72% |
Employees
4
Sector
Pharmaceuticals
